<Disease><Name>MUCOPOLYSACCHARIDOSIS II; HUNTER SYNDROME</Name><Synonym>MPS2</Synonym><OMIM><Number>309900</Number><URL>http://omim.org/entry/309900</URL></OMIM><Orphanet><Number>580</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=580</URL></Orphanet><Protein><Number>Iduronate-2-sulfatase</Number><URL>http://www.uniprot.org/uniprot/P22304</URL></Protein><ExPASy><Number>3.1.6.13</Number><URL>http://enzyme.expasy.org/EC/3.1.6.13</URL></ExPASy><Gene>Xq28Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Iduronate 2-sulfatase (Hunter syndrome)
</Gene><ICD>E76.1</ICD><Summary>rare (1:100000, 1:70000 Israel);X-linked recessive ;2 types: ;- type A (severe) ;- type B (mild)</Summary><Symptoms><symtomp><id>3210</id><symptom>apnea</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2352</id><symptom>carpal tunnel syndrome</symptom><category>SKELETAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2247</id><symptom>contractures, joints</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2300</id><symptom>coronary heart disease</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3245</id><symptom>dwarfism</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3056</id><symptom>hip dysplasia, hip dyslocation</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1960</id><symptom>hydrocephalus</symptom><category>HEAD | NERVOUS SYSTEM</category></symtomp><symtomp><id>3222</id><symptom>hypertrichosis</symptom><category>SKIN</category></symtomp><symtomp><id>3913</id><symptom>infections (respiratory tract/system)</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1910</id><symptom>inguinal hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2304</id><symptom>joint stiffness</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1852</id><symptom>macroglossia, large/protuding tongue</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3780</id><symptom>mongolian spots</symptom><category>SKIN</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2353</id><symptom>obstructive airway disease / asthma</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4071</id><symptom>otitis media, recurrent</symptom><category>EARS</category></symtomp><symtomp><id>3800</id><symptom>restrictive lung disease</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1730</id><symptom>retinal or macular degeneration</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3385</id><symptom>skin, abnormal</symptom><category>SKIN</category></symtomp><symtomp><id>2008</id><symptom>skin, thickened</symptom><category>SKIN</category></symtomp><symtomp><id>2250</id><symptom>skoliosis, kyphoskoliosis</symptom><category>BODY | SKELATAL DEFECT</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1816</id><symptom>thick or large lips / macrocheilia</symptom><category>HEAD</category></symtomp><symtomp><id>1909</id><symptom>umbilical hernia</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2355</id><symptom>valvular heart disease</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2248</id><symptom>X-ray, abnormalities</symptom><category>LABORATORY FINDINGS</category></symtomp></Symptoms><Metabolites><metabolite><id>899</id><name>Iduronide-2-sulfate sulfatase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7402</id><title>Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome</title><author>Eisengart JB,</author><journal>Mol Genet Metab Rep</journal><year>2020</year><book /><volume>22</volume><number>0</number><pages>100570</pages><co_aut>et al.</co_aut></literature><literature><id>7403</id><title>Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome</title><author>Grant N</author><journal>Mol Genet Metab Rep</journal><year>2020</year><book /><volume>22</volume><number>0</number><pages>100566</pages><co_aut /></literature><literature><id>7988</id><title>Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis</title><author>Patel P,</author><journal>J Child Neurol</journal><year>2020</year><book /><volume>35</volume><number>6</number><pages>410-417</pages><co_aut>et al.</co_aut></literature><literature><id>6954</id><title>Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England</title><author>Broomfield A,</author><journal>Mol Genet Metab</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4814</id><title>Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review</title><author>Bradley LA,</author><journal>Genet Med</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Haddow HRM, Palomaki GE</co_aut></literature><literature><id>5716</id><title>Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II</title><author>Rybova J,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4815</id><title>Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)</title><author>da Silva EM,</author><journal>Cochrane Database Syst Rev</journal><year>2016</year><book /><volume>2</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4816</id><title>Management of the behavioural manifestations of Hunter syndrome</title><author>Roberts J,</author><journal>Br J Nurs</journal><year>2016</year><book /><volume>25</volume><number>1</number><pages>26-30</pages><co_aut>Stewart C, Kearney S</co_aut></literature><literature><id>4817</id><title>Mucopolysaccharidosis Type II</title><author>Scarpa M</author><journal>GeneReviews&#174; [Internet]</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>4831</id><title>Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB</title><author>Shimada T,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>1-13</pages><co_aut>et al.</co_aut></literature><literature><id>4818</id><title>Mucopolysaccharidosis type II, Hunters syndrome</title><author>Tylki-Szymanska A</author><journal>Pediatr Endocrinol Rev Suppl</journal><year>2014</year><book /><volume>1</volume><number>0</number><pages>107-113</pages><co_aut /></literature><literature><id>4501</id><title>Mongolian spots: How important are they?</title><author>Gupta D,</author><journal>World J Clin Cases</journal><year>2013</year><book /><volume>1</volume><number>8</number><pages>230-232</pages><co_aut>Thappa DM</co_aut></literature><literature><id>2258</id><title>Ultrastructural findings of cutaneous nerves in patients with Hunters syndrome following hematopoietic stem cell transplant</title><author>Ochiai T</author><journal>Med Mol Morphol</journal><year>2005</year><book /><volume>38</volume><number>2</number><pages>118-122</pages><co_aut>et al.</co_aut></literature><literature><id>2259</id><title>Mongolian spots in the newborn: do they mean anything?</title><author>Snow TM</author><journal>Neonatal Netw</journal><year>2005</year><book /><volume>24</volume><number>1</number><pages>31-33</pages><co_aut /></literature><literature><id>2260</id><title>Mucopolysaccharidosis type II in females: case report and review of literature</title><author>Tuschl K</author><journal>Pediatr Neurol</journal><year>2005</year><book /><volume>32</volume><number>4</number><pages>270-272</pages><co_aut>et al.</co_aut></literature><literature><id>2257</id><title>Significance of extensive Mongolian spots in Hunters syndrome</title><author>Ochiai T</author><journal>Br J Dermatol</journal><year>2003</year><book /><volume>148</volume><number>6</number><pages>1173-1178</pages><co_aut>et al.</co_aut></literature><literature><id>2261</id><title>Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report</title><author>Muenzer J</author><journal>Acta Paediatr Suppl</journal><year>2002</year><book /><volume>91</volume><number>0</number><pages>98-99</pages><co_aut>et al.</co_aut></literature><literature><id>102</id><title>The mucopolysaccharidoses</title><author>Neufeld EF</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2465-2494</pages><co_aut>M&#252;nzer J</co_aut></literature></Literatures></Disease>